Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

John Wiley Sons Cl B (WLYB)

John Wiley Sons Cl B (WLYB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Wiley Announces Quarterly Dividend; Allocated $126 million to Dividends and Repurchases in 9 Months of Fiscal 2026

Wiley (NYSE: WLY), a global leader in authoritative content and research intelligence for the advancement of scientific discovery, innovation, and learning, today announced that its Board...

WLY : 37.96 (+0.90%)
WLYB : 38.56 (+4.23%)
AI Momentum, Material Margin Expansion, and Cash Flow Growth Highlight Wiley’s Third Quarter 2026

Wiley (NYSE: WLY), a global leader in authoritative content and research intelligence for the advancement of scientific discovery, innovation, and learning, today reported results for the third quarter...

WLY : 37.96 (+0.90%)
WLYB : 38.56 (+4.23%)
Wiley and OpenEvidence Partner to Deliver Trusted Research to Physicians at the Point of Care

A new content agreement deepens the medical literature physicians can retrieve, synthesize, and verify through AI-assisted clinical questions

WLY : 37.96 (+0.90%)
WLYB : 38.56 (+4.23%)
Wiley Schedules Third Quarter 2026 Earnings Release and Conference Call

Wiley (NYSE: WLY and WLYB) , a global leader in authoritative content and research intelligence for the advancement of scientific discovery, innovation, and learning, will release its third...

WLY : 37.96 (+0.90%)
WLYB : 38.56 (+4.23%)
Wiley to Expand Prestigious Advanced Journals Portfolio

Wiley will launch eight new Advanced journals by the end of 2026—with more planned over the next several years—offering researchers in life, health and social sciences high-impact venues to publish...

WLY : 37.96 (+0.90%)
WLYB : 38.56 (+4.23%)
Wiley Appoints Armughan Rafat as Chief AI and Data Services Officer

Proven Leader to Accelerate Wiley’s AI Momentum and Growth in Corporate R&D Markets

WLY : 37.96 (+0.90%)
WLYB : 38.56 (+4.23%)
Wiley Announces Quarterly Dividend; Recently Increased Share Repurchase Allocation and Raised Dividend for 32nd Consecutive Year

Wiley (NYSE: WLY), a global leader in authoritative content and research intelligence for the advancement of scientific discovery, innovation, and learning, today announced that its Board...

WLY : 37.96 (+0.90%)
WLYB : 38.56 (+4.23%)
Wiley Increases Fiscal 2026 Share Repurchase Allocation to $100 million

Company recently reported strong Q2 margin expansion and reaffirmed full year earnings and free cash flow guidance

WLY : 37.96 (+0.90%)
WLYB : 38.56 (+4.23%)
Research Growth, AI Momentum, and Margin Expansion Highlight Wiley’s Second Quarter 2026

Wiley (NYSE: WLY), a global leader in authoritative content and research intelligence for the advancement of scientific discovery, innovation, and learning, today reported results for the second quarter...

WLY : 37.96 (+0.90%)
WLYB : 38.56 (+4.23%)
Wiley Schedules Second Quarter 2026 Earnings Release and Conference Call

Wiley (NYSE: WLY and WLYB) , a global leader in authoritative content and research intelligence for the advancement of scientific discovery, innovation, and learning, will release its second...

WLY : 37.96 (+0.90%)
WLYB : 38.56 (+4.23%)

Barchart Exclusives

Micron Stock Cools Off — Is MU Now Too Cheap to Ignore?
Despite the decline, Micron’s underlying growth outlook remains strong. Analysts expect Micron’s earnings to increase sharply in the coming years. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.